chrisvoncsefalvay/vaers-outcomes huggingface dataset:
By October 8th patient felt extreme shoulder pain. On 10/23/17 appt. with Dr. - given 10-23-17 appt. with Dr.-given complete physical. Diagnosis: frozen shoulder. Five additional appointments - condition appointments-condition worsened. Twelve appointments with PT - no Therapist-no improvement. Pain spread throughout body, limb weakness, weight loss, could not hold eating utensils. Doctor and Physical Therapist Providers both recommended neurology group/no appt. until 02-03-18 apt until 2-03-18 died waiting. My husband was an active active, robust man until this vaccine shot. He weighed 175 pounds on October 1st, 2017, and at his last appointment on January 3rd, 2018, he registered 150 pounds. He could not hold a fork or juice glass. Both Dr. and Therapist said they could no longer help him and recommended the Neurologist Neurologists the first week in January. His appointment was set for February 3rd and he called every day to see if there was a cancellation; but he died 10 ten days before. He awakened at 1:00 to use the bathroom. When his legs gave out, I called 911 and did chest thrusts. The ambulance took him to the Hospital hospital where he died within one hour. Therapist said from his first appointment, on November 15th, that the cause was the flu shot. All symptoms point to Chronic Inflammatory Demyelinating Polyneuropathy. Here is a strong man who had never been hospitalized since a tonsillectomy at age 5 who dies from a vaccination designed to keep him healthy. What are the statistics of death from a flu shot? What compensation for wrongful death is covered by the FDA? Pharmacy certainly shuns responsibility for having an inexperienced girl administer the shot. I think there should be a precise warning given at the time of the shot, shot as opposed to the generic list of possible side effects. We wasted months treating a frozen should shoulder rather than see seeing a neurologist. I have saved all receipts and reports in my file. And you are welcome to verify husband's patient's physical condition from any of the 136 units in our condo who saw him walking daily, fishing, playing tennis, etc. You can also check with our neighbors who saw him boating, cycling, gardening, etc. etc.. One week before the vaccination he drove 1600 miles (with overnight stops along the way, of course). I will, and do, miss my loving husband of fifty three years-as years - as do our children and his twin sister. It is a difficult time for all of us.
Information has been received from a physician concerning a patient who was vaccinated with three doses of ROTATEQ. The physician stated that the patient experienced mild diarrhea after receiving the first and second doses of ROTATEQ. Third dose of ROTATEQ was administered with "other vaccines" who was still experiencing mild diarrhea at the time of vaccination. The patient sought medical attention through an office visit. A stool sample was performed. The patient was not recovered at the time of this report. There was no product quality complaint. No further information is available.
No adverse symptoms.  Flumist given instead of injectable H1N1 to pregnant client. H1N1 - pregnancy 11/2/09:  Prenatal records received for dates of service 7/27/09 to 10/28/09. Dx:  Pregnant pt. at 29 weeks gestation received LAIV H1N1 vaccine EDD: 1/5/10  Assessment:  As above.
received vaccines after a temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 63-year-old patient who received Herpes zoster (Shingles vaccine) (batch number 7KG39) for prophylaxis.   On 25-JAN-2023, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incorrect storage of drug (Verbatim: received vaccines after a temperature excursion). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 14-Apr-2023 The reporter consented to follow-up. This case is for one of 119 patients, reported by same reporter. The patient received unstable vaccine after a temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2023AMR055743:same reporter
Not consistence headache, severe pain and sharp pains in head; occurring every couple minute, every 3 minutes or so; Severe pain on the right side, around my eye; affecting my right side and it's affecting my eye; This is a spontaneous report from a contactable consumer (patient) or other non-Health Professional. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. on an unspecified date the patient experienced not consistence headache, severe pain and sharp pains in head; occurring every couple minute, every 3 minutes, patient further stated that severe pain on the right side, around eye affecting right side and it affecting eye. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
HEAD TENSION; NUMBNESS IN ARMS AND LEGS; OCULAR MIGRAINE; LEG CRAMPS/MUSCLE ACHES IN LEGS; IMMEDIATE PAINFUL REACTION AT INJECTION SITE (PAINFUL INJECTION); This spontaneous report received from a patient concerned a 35 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 23-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 23-SEP-2021, the patient experienced immediate painful reaction at injection site (painful injection). On 24-SEP-2021, the patient experienced ocular migraine. On 24-SEP-2021, the patient experienced leg cramps/muscle aches in legs. On 01-OCT-2021, the patient experienced head tension. On 01-OCT-2021, the patient experienced numbness in arms and legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ocular migraine on 24-SEP-2021, leg cramps/muscle aches in legs on 25-SEP-2021, and immediate painful reaction at injection site (painful injection) on 23-SEP-2021, and had not recovered from numbness in arms and legs, and head tension. This report was non-serious.; Sender's Comments: V0. medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Skin irritated by any type of metal, breaks out in hives from the touch of it.  Unable to eat fish, shrimp and chocolate after taking the vaccine.  She was never allergic to anything before taking the vaccine.  Irregular heart beats.
This spontaneous report was received from a medial assistant and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported. On 15-JUL-2016, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # M001200, dose, route of administration and expiration date was not reported). This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (huge swelling in my arm), ERYTHEMA (and glowing red), NASAL CONGESTION (congestion), DIARRHOEA (diarrhea) and PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced NASAL CONGESTION (congestion), DIARRHOEA (diarrhea) and PYREXIA (fever). On an unknown date, the patient experienced PERIPHERAL SWELLING (huge swelling in my arm) and ERYTHEMA (and glowing red). At the time of the report, PERIPHERAL SWELLING (huge swelling in my arm), ERYTHEMA (and glowing red), NASAL CONGESTION (congestion), DIARRHOEA (diarrhea) and PYREXIA (fever) outcome was unknown. No concomitant medications reported. No treatment information was provided.
This is a spontaneous report obtained from a contactable consumer (patient). A 66-year-old female patient received PREVNAR 13 on an unspecified date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced swelling and rash at the injection site. The rash seemed to be spreading and at time of this report it was down to her elbow and going around to the back of his arm; rash was reported as worsened. The patient was treated with BENADRYL and cold packs. The patient did not recover from the events at time of this report. The information on the lot number has been requested.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Reporter stated that no adverse reactions were reported by any patients.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at this time. It was reported that no adverse reactions were reported by any patients. Reporter does not have details on how many patients were impacted or any information on patients.
PATIENT RECEIVED MORE THAN THE RECOMMENDED DOSES OF COVID-19 VACCINE. FIRST VACCINE RECEIVE WAS JANSSEN ON 4/9/2021, THEN PFIZER ON 4/29/2021. SIDE EFFECTS, TREATMENT, AND OUTCOME UNKNOWN.
Patient was anxious stated she had an eaction (rash) to flu vaccine in past. refused ema. observed for 30 minutes
his father complained of unspecified tiredness which has improved but not resolved; This spontaneous report was received from a consumer, referring to his father, a 82 year old male patient. The patient did not have any concomitant therapies or medical history. The patient's drug allergy/reaction included penicillin.  On 25-SEP-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) for prophylaxis (strength, dose, route, frequency, lot# and expiration date were not reported).  On 28-SEP-2019, the patient complained of unspecified tiredness (fatigue). The patient did not seek medical attention and diagnostic laboratories were not performed.  At the time of reporting, the outcome of fatigue was reported as improved but not resolved (resolving)  (also reported as "not recovered"). The causality assessment was not provided.
Started with an itch that was scratched, skin remained intact, by the evening of 1/13/11 an oblong area about 1.5 - 2 inches long and 1 inch wide developed with redness and a hard center.Patient went to MD on Mon and was diagnosed as infection with a possible allergic component as antihistamine and antibiotic were prescribed. The area has lessened in redness and hardness but the size has slightly enlarged.
Fever blisters branching out / popping up on nose area - 7 total so far, patient was contacting doctor.
15y/o male brought in for a well-adolescent visit was given Pfizer Covid vaccine(gray cap). Per a reporter, ?member given monovalent, the order stated bivalent?.  The parent, manager, and physician were notified of the error.
approx 28hr p/vax devel hive rash all over body, eyelids swollen perioral cyanosis, much quieter than nl, given 02 & transferred to ER;given IV Benadryl, adm for observation; next day was fine
infection at injection site area. Red area on skin.  Patient was prescribed an antibiotic from her physician to treat.
Update: Already made one report on January 13th describing how right hand and upper lip was numb. Right hand numbness lasted 4 hours then returned to normal. Upper lip numbness lasted 10+ hours and resolved sometime during that night when I was sleeping. On 14th when woke up (numbness gone) but had about an inch redness around injection site with a 7mm× 7mm lump under skin where injection given sore to touch.  On 15th site reaction still there and felt low on energy. Today 16th then redness seems to be a bit better and taking on more darkish hue (maybe turning into bruise?) And lump feels slightly smaller and not as sore. So site reaction might be on the way towards healing. However today I have been fatigued and drained feeling, low on energy. ( Dr notified of numbness post injection, and pic of arm via online portal. (No reply from Dr as of this date).  Seem to be on mend other than increasing fatigue, low on energy.
I had chest pain, shortness of breath and heart palpitations in the days following the second moderna shot. I was subsequently hospitalized. Tests confirmed Hypertrophic Cardiomyopathy. I am now on medication for it.
On the 25th in the evening, I started getting a cough. On the 26th, my cough got really bad. I had a lack of appetite and I was sleeping a lot. On the 26th at midnight, I took a test and it was positive, but the test was expired. I wasn't confident on it. On the 27th I took another test at 8:30AM, and it was expired but it came back positive. I had a cough, no fever, shortness of breath, a headache, and a lack of appetite and fatigue. I called the research group and asked them what to do about RSV and Flu. They said to do some swabs and asked to come in on the 29th. They did COVID-19 swabs and other tests and I tested positive for COVID-19 and everything else came back negative. After about the 5th or 6th day, my symptoms were lighter but I was still showing positive until 01/10/2023. I had a mammogram so I took a test before going and I was negative on the 01/10/2023. I never took any medication and I wasn't prescribed anything. I honestly started feeling better on 12/31/2022 which was about the 5th or 6th day of the infection.
28FEB92 pt irritable but consolable p/DTP yesterday; Today dec PO, especially last bottle; less smiling seems pale now better; rxn lt thigh; t100.6;
Patient received booster dose and began waiting for 15 minutes. He came to the counter and stated he felt a little funny. Pharmacist had him sit down in the waiting area and as he sat down he slumped into his chair, lost consciousness. He was out for approx. 30 seconds before he came back. Called EMS to come check him out and his wife came to meet him.
Its almost dizziness; Feels weak; Soreness where the shot went (left arm); Had episodes of nausea; Very, very tired; Mild diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Mild diarrhea), DIZZINESS (Its almost dizziness), ASTHENIA (Feels weak), VACCINATION SITE PAIN (Soreness where the shot went (left arm)) and NAUSEA (Had episodes of nausea) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced DIARRHOEA (Mild diarrhea). 21-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness where the shot went (left arm)), NAUSEA (Had episodes of nausea) and FATIGUE (Very, very tired). On 23-Feb-2021, the patient experienced ASTHENIA (Feels weak). On an unknown date, the patient experienced DIZZINESS (Its almost dizziness). On 26-Feb-2021, DIARRHOEA (Mild diarrhea), DIZZINESS (Its almost dizziness), ASTHENIA (Feels weak), VACCINATION SITE PAIN (Soreness where the shot went (left arm)), NAUSEA (Had episodes of nausea) and FATIGUE (Very, very tired) had resolved.            This case was linked to MOD-2021-023222 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: New event added. The outcome of the events changed from unknown to recovered.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In approximately 2016, (since 08-FEB-2016), the patients were vaccinated with improperly stored doses of ROTATEQ lot # L026067, expiration date 06-APR-2017; lot # L029617, expiration date 19-MAY-2017; lot # L027076, expiration date 25-MAY-2017; lot # L033545, expiration date 30-MAY-2017; lot # M004508, expiration date 29-JUN-2017; lot # M014318, expiration date 30-SEP-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccine experienced the temperature excursion of 9 degrees Celsius for 9 hours, 0.3 degrees Celsius for 837 hours and 30 degrees Fahrenheit for 542 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Follow up has been received on 14-SEP-2016, reporting the administered vaccine doses that have experienced multiple temperature excursions. It was reported that the patients were vaccinated with ROTATEQ (lot# L029617, expiration date: 19-MAY-2017) on 02-MAR-2016, 04-MAR-2016, 07-MAR-2016, 09-MAR-2016, 14-MAR-2016, 15-MAR-2016, 16-MAR-2016, 18-MAR-2016, 21-MAR-2016, 22-MAR-2016, 23-MAR-2016, 26-MAR-2016, 29-MAR-2016 and 05-APR-2016. The longest duration of temperature excursion with ROTATEQ was 18 hours and the inappropriate temperature range was between 0.3 and 1.7 Celsius degrees. The temperature excursions were detected by a data logger. Additional information has been requested. General, product information and narrative were updated.
Systemic: Flushed / Sweating-Medium, Additional Details: patient became flush approximately 5 minutes into his 15 minute observation period.  Placed patient on floor and elevated legs.  Patient was able to return to a sitting position in a chair approximately 8 minutes later.  BP during epidose was 130/88 and pulse was 60 per automatic blood pressure cuff machine.  Patient also stated he was light-headed as well.  Patient was doing much better when he left the observation area.
Pt expressed anxiety over receiving vaccine, then developed lightheadedness. Denies chest pain, SOB, HA.
The pt complained of redness, tenderness, soreness for 3 days at the injection site. The pt also experienced mild aches, fatigue, no elevated temp.
Fever 101.3 Muscle aches back & neck Stiff joints (shoulders/ rotator cuff)
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information has been provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 24-JUL-2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a drug store, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 30-SEP-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the pt suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Erythematous area of 10cm @ inject site w/intact skin, burning, itchy & slightly swollen;
Swollen, reddish-pink area on arm at injection site.  Slightly warm to touch and itchy.  Appears to be diminishing  (reporting about 16 hours after noticed it).